Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Luma Group is a venture capital organization based in the United States, founded by Josh Fink and Themasap Khan, PhD. The firm focuses on early and mid-stage biotechnology companies, emphasizing strong scientific principles and data-driven approaches. They provide strategic, operational, and scientific support alongside financial capital.
Luma Group invests in biotechnology companies at various stages, including pre-seed, seed, seed-plus, series A, and series B. Their investment strategy targets therapies, diagnostics, and medical devices that can scale patient impact, particularly in precision medicine and breakthrough biology. The firm emphasizes strong scientific foundations and data in its investment decisions.
Yes, Luma Group often leads investment rounds, particularly in early-stage biotech companies where they can provide significant strategic and operational support.
Luma Group is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their scientific and operational support model.
Specific details about Luma Group's fund size or assets under management are not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.